Company: BSX
Filing Date: 2025-05-01
Form Type: 10-Q
Source: 0000885725-25-000026
Chunk: 42

Company: BOSTON SCIENTIFIC CORP
Filing Date: 2025-05-01
Form: 10-Q
Item: Part I, Item 1
Chunk 42
---
, interest rates, the creditworthiness of the counterparty for unrealized gain positions and our own creditworthiness for unrealized loss positions. In certain instances, we may utilize financial models to measure fair value of our derivative and nonderivative instruments. In doing so, we use inputs that include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, other observable inputs for the asset or liability and inputs derived principally from, or corroborated by, observable market data by correlation or other means. The following are the balances of our derivative and nonderivative assets and liabilities: Location on Unaudited Consolidated Balance Sheets(1)As of(in millions)March 31, 2025December 31, 2024Derivative and Nonderivative Assets:   Designated Hedging Instruments  Forward currency contractsOther current assets$122 $149 Forward currency contractsOther long-term assets11 79   133 228 Non-Designated Hedging Instruments   Forward currency contractsOther current assets99 156 Total Derivative and Nonderivative Assets $232 $384 Derivative and Nonderivative Liabilities:   Designated Hedging Instruments  Forward currency contractsOther current liabilities$12 $1 Forward currency contractsOther long-term liabilities19 — Foreign currency-denominated debt(2)Long-term debt969 930   1,000 931 Non-Designated Hedging Instruments   Forward currency contractsOther current liabilities47 59 Total Derivative and Nonderivative Liabilities $1,047 $990 (1) We classify derivative and nonderivative assets and liabilities as current when the settlement date of the contract is one year or less.(2) Foreign currency-denominated debt is the €900 million debt principal associated with our December 2027 Notes designated as a net investment hedge. A portion of this notional is subject to de-designation and re-designation based on changes in the underlying hedged item.

16

Recurring Fair Value MeasurementsOn a recurring basis, we measure certain financial assets and financial liabilities at fair value based upon quoted market prices. Where quoted market prices or other observable inputs are not available, we apply valuation techniques to estimate fair value. FASB ASC Topic 820 establishes a three-level valuation hierarchy for disclosure of fair value measurements. The category of a financial asset or a financial liability within the valuation hierarchy is based upon